AF
OMIC

Amalgamated Financial’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Amalgamated Financial’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$24K Buy
+128
New +$29.6K ﹤0.01% 2690

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amalgamated Financial's OMIC Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2022: 128 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #2690 among its holdings.

69 funds tracked by Wall St. Rank hold OMIC as of Q1 2022.

  • Amalgamated Financial held 128 shares of Singular Genomics Systems, Inc. Common Stock worth $24K as of Q1 2022.
  • Singular Genomics Systems, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • Singular Genomics Systems, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2690 holding.
  • 69 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.